Skip to main content

Advertisement

SpringerLink
Log in

The use of botulinum toxin type A in headache treatment

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

  • Four percent to 5% of the general population suffers from chronic daily or near daily headache. A majority of them are chronic migraine (transformed migraine), and the rest are chronic tension-type headaches.

  • Prophylactic treatments of migraine and chronic tension-type headache are far from satisfactory because of lack of good efficacy, intolerable side effects, development of tachyphylaxis over long-term use, and drug interactions. Comorbidities and analgesic overuse complicate matters further.

  • There has been an increasing search for more effective treatment for chronic headache, which would result in “modification of the disease.” Botulinum toxin type A is an emerging treatment for such patients whose headaches are poorly controlled with currently available prophylactic pharmacotherapy or in patients who do not tolerate them and are unable to continue them. Contraindications to acute migraine therapy such as triptans may also be an indication for alternative treatments like botulinum toxin type A.

  • A number of double blind and open-label trials have been done for migraine and chronic tension-type headache. Although some of the well designed double blind, placebo-controlled, randomized clinical trials are in progress, it has been the clinical experience of many physicians that botulinum toxin type A cuts down the frequency and severity of headaches, improves disability scales, improves quality of life, and reduces the need for acute medications.

  • Repeated use of botulinum toxin type A is needed to sustain long-term improvement, and long-term results indicate lack of tachyphylaxis in the majority of patients. Botulinum toxin type A is well tolerated and totally free of many longterm side effects, which are seen with other prophylactic agents.

  • The clinician may be well advised to consider botulinum toxin type A in the most refractory forms of chronic headaches including chronic migraine and chronic tension-type headache.

  • Appropriate injection techniques, selection of injection sites, and appropriate doses are necessary for success.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Jankovic J, Brin MF: Botulinum toxin: historical perspective and potential new indications. Muscle Nerve 1997, 20(suppl):S129-S145.

    Article  Google Scholar 

  2. Arnon SS, Schecter R, Inglesby TV, et al.: Botulinum toxin as a biological weapon: medical and public health management. JAMA 2001, 285:1059–1070. A good article.

    Article  PubMed  CAS  Google Scholar 

  3. Jankovic J, Brin MF: Therapeutic uses of botulinum toxin. N Eng J Med 1991, 324:1186–1194.

    Article  CAS  Google Scholar 

  4. Snow BJ, Tsui JKC, Bhatt MH, et al.: Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol 1990, 28:512–515.

    Article  PubMed  CAS  Google Scholar 

  5. Pasricha PJ, Ravich WJ, Kaloo AN: Botulinum toxin for achalasia. Lancet 1999, 341:244–245.

    Article  Google Scholar 

  6. Brisinda G, Maria G, Bentivoglio AR, et al.: A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Eng J Med 1999, 341:65–69.

    Article  CAS  Google Scholar 

  7. Knusel B, Grant M, Loesser JD: Intramuscular injection of botulinum toxin type A in chronic low back pain associated with muscle spasm. Poster presented at the American Pain Society Meeting; San Diego, CA. November 1998;

  8. Jankovic J, Schwartz K: Botulinum toxin injections for cervical dystonia. Neurology 1990, 40:277–280.

    Article  PubMed  CAS  Google Scholar 

  9. Relja M: Treatment of tension-type headache by local injection of botulinum toxin. Eur J Neurol 1997, 4(suppl):S1-S73.

    Article  Google Scholar 

  10. Anand K, Singh MM, Prasad A: Botulinum toxin type A in prophylactic treatment of migraine. Poster presented at the 17th World Congress of Neurology; London, UK. June 17–22, 2001;

  11. Robbins L: Botulinum toxin for cluster headache: 6 cases [abstract]. Cephalalgia 2001, 21:499.

    Google Scholar 

  12. Gobel H, Heinze A, Heinze K: Botulinum toxin A in the treatment of chronic paroxysmal hemicrania-a case report [abstract]. Cephalalgia 2001, 21:506.

    Article  Google Scholar 

  13. Gobel H, Heinze A, Heinze K: Botulinum toxin A is effective is cases of oromandibular dysfunction even if previous bite splint therapy has proved unsuccessful. Cephalalgia 2001, 21:514.

    Article  Google Scholar 

  14. Montecucco C: Clostridial neurotoxins: the molecular pathogenesis of tetanus and botulism. Curr Top Microbiol Immunol 1995, 195:1–278.

    Google Scholar 

  15. Alderson K, Holds JB, Anderson RL: Botulinuminduced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm. Neurology 1991, 41:1800–1805.

    PubMed  CAS  Google Scholar 

  16. Klein AW: Complications and adverse reactions with the use of botulinum toxin. Semin Cutan Med Surg 2001, 20:109–120.

    Article  PubMed  CAS  Google Scholar 

  17. de Pavia A, Meunier FA, Molgo J, et al.: Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci 1999, 96:3200–3205. A good article.

    Article  Google Scholar 

  18. Aoki KR: Pharmacology and immunology of botulinum toxin serotypes. J Neurol 2001, 248(suppl):1–10. An important paper.

    Article  Google Scholar 

  19. Rollnik JD, Karst M, Fink K, Dengler R: Botulinum toxin type A and EMG: a key to the understand of chronic tension-type headaches? Headache 2001, 41:985–989. Outstanding review.

    Article  PubMed  CAS  Google Scholar 

  20. Zwart JA, Bovim G, Sand T, Sjaastad O: Tension headache: botulinum toxin paralysis of temporal muscles. Headache 1994, 34:458–462.

    Article  PubMed  CAS  Google Scholar 

  21. Welch MJ, Punkiss JR, Foster KA: Sensitivity of embryonic rat dorsal root ganglia neurons to clostridium botulinum neurotoxins. Toxincon 2000, 38:245–258.

    Article  CAS  Google Scholar 

  22. Yamamura H, Malick A, Chamberlin NL, Burnstein R: Cardiovascular and neuronal responses to head stimulation reflect central sensitization and cutaneous allodynia in a rat model of migraine. J Neurophysiol 1999, 81:479–493.

    PubMed  CAS  Google Scholar 

  23. Fusco BM, Colantoni O, Giavovazzo M: Alteration of central excitation circuits in chronic headache and analgesic misuse. Headache 1997, 37:486–491.

    Article  PubMed  CAS  Google Scholar 

  24. Silberstein S, Mathew NT, Saper J: Botulinum toxin type A as a migraine preventive treatment. Headache 2000, 40:445–450.

    Article  PubMed  CAS  Google Scholar 

  25. Brin MF, Swope DM, O’brien C, et al.: Botox for migraine: double-blind, placebo-controlled, regionspecific evaluation. Cephalalgia 2000, 20:421–422.

    Article  Google Scholar 

  26. Binder WJ, Brin MF, Blitzer A, et al.: Botulinum toxin type A for treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg 2000, 123:669–676.

    Article  PubMed  CAS  Google Scholar 

  27. Binder WJ, Brin MF, Blitzer A, Pogoda JM: Botulinum toxin type A for treatment of migraine. Semin Cutan Med Surg 2001, 20:93–100.

    Article  PubMed  CAS  Google Scholar 

  28. Mauskop A, Basdeo R: Botulinum toxin A is effective prophylactic therapy for migraines. Cephalalgia 2000, 20:422.

    Google Scholar 

  29. Tatarian GT: Effect of botulinum toxin type A on patients with menstrual migraine headache: a retrospective chart view. Presented at Diamond Practicing Physician’s Approach to the Difficult Headache Patient; Lake Buena Vista, FL. July 17–21, 2001;

  30. Parcells PR: A retrospective chart review of repeated doses of botulinum toxin type A for the treatment of migraine headache. Presented at Diamond Practicing Physician’s Approach to the Difficult Headache Patient; Lake Buena Vista, FL. July 17–21, 2001;

  31. Smuts JA, Barnard PWA: Botulinum toxin type A in the treatment of headache syndromes: a clinical report of 79 patients. Cephalalgia 2000, 20:332.

    Article  Google Scholar 

  32. Schmitt WJ, Slowey E, Fravi N, et al.: Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache 2001, 41:658–664. A good article.

    Article  PubMed  CAS  Google Scholar 

  33. Rolnik JD, Tannenberger O, Schubert M, et al.: Treatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study. Headache 2000, 40:300–305. An excellent paper.

    Article  Google Scholar 

  34. Smuts JA, Baker MK, Smuts HM, et al.: Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. Eur J Neurol 1999, 6(suppl):S99-S102. A good article.

    Article  Google Scholar 

  35. Relja MA, Klepac N: Botulinum toxin type A as a prophylactic treatment in chronic tension-type headache: long-term follow-up study. Neurology 2001, 56(suppl):A349-A350.

    Google Scholar 

  36. Freund BJ, Schwartz M: Treatment of chronic cervicalassociated headache with botulinum toxin A: a pilot study. Headache 2000, 40:231–236.

    Article  PubMed  CAS  Google Scholar 

  37. Gobel H, Heinze A, Heinze-Kuhn K, Jost WH: Evidencebased medicine: botulinum toxin A in migraine and tension-type headache. J Neurol 2001, 248(suppl):34–38.

    Article  PubMed  CAS  Google Scholar 

  38. Blumenfeld A: Decreases in medication use and cost after botulinum toxin type A treatment for intractable chronic headache: case studies. Presented at Diamond Practicing Physician’s Approach to the Difficult Headache Patient; Lake Buena Vista, FL. July 17–21, 2001;

Download references

Author information

Authors and Affiliations

  1. Houston Headache Clinic, Park Plaza Professional Building, 1213 Hermann Drive, Suite 350, 77004, Houston, TX, USA

    Ninan T. Mathew MD, DM, FRCP(C) & Alex O. Kaup MD

Authors
  1. Ninan T. Mathew MD, DM, FRCP(C)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alex O. Kaup MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mathew, N.T., Kaup, A.O. The use of botulinum toxin type A in headache treatment. Curr Treat Options Neurol 4, 365–373 (2002). https://doi.org/10.1007/s11940-002-0047-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-002-0047-8

Keywords

Search

Navigation